{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:54:42Z","timestamp":1782402882534,"version":"3.54.5"},"reference-count":44,"publisher":"Portland Press Ltd.","issue":"9","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background: Sphingolipids mainly consist of ceramides (Cer), sphingomyelins (SM) and glycosphingolipids. Sphingolipids are related with coronary heart disease and metabolic disease, but there\u2019re few studies about cerebrovascular disease. The purpose was to detect sphingolipids in plasma of patients with large artery atherosclerosis (LAA) cerebrovascular disease and cerebral small vessel disease (CSVD) to explore the similarities and differences of pathogenesis of the two subtypes.<\/jats:p>\n               <jats:p>Methods: 20 patients with LAA cerebrovascular disease, 20 patients with age-related CSVD, 10 patients with Fabry disease and 14 controls were enrolled from October 2017 to January 2019. Ultra-high performance liquid chromatography-quadruple-time-of-flight mass spectrometry\/mass spectrometry was used to determine sphingolipids. Univariate combined with multivariate analysis was used for comparison. Receiver operating characteristic curves were used to determine sensitivities and specificities.<\/jats:p>\n               <jats:p>Results: 276 sphingolipids were detected, including 39 Cer, 3 ceramide phosphates, 72 glycosphingolipids and 162 SM. (1) Cer (d36:3), Cer (d34:2), Cer (d38:6), Cer (d36:4) and Cer (d16:0\/18:1) were increased in LAA; SM (d34:1), Cer (d34:2), Cer (d36:4), Cer (d16:0\/18:1), Cer (d38:6), Cer (d36:3) and Cer (d32:0) were increased in age-related CSVD. (2) Cer (d36:4) and SM (d34:1) were increased in age-related CSVD compared with LAA. (3) Total trihexosyl ceramides were increased in Fabry group compared with control (P&amp;lt;0.05); SM (d34:1) was increased in Fabry group.<\/jats:p>\n               <jats:p>Conclusions: Ceramides are increased in both LAA and age-related CSVD, which may be related to similar risk factors and pathophysiological process of arteriosclerosis; SM is increased in both age-related CSVD and Fabry disease, suggesting that increased SM may be associated with CSVD. Glycosphingolipids, trihexosylceramides in particular, are increased in Fabry disease.<\/jats:p>","DOI":"10.1042\/bsr20201519","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T10:54:49Z","timestamp":1598266489000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease"],"prefix":"10.1042","volume":"40","author":[{"given":"Qian","family":"You","sequence":"first","affiliation":[{"name":"Department of Neurology, Peking University First Hospital 100034, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital 100034, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9658-4869","authenticated-orcid":false,"given":"Zemou","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital 100034, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqiang","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital 100034, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital 100034, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital 100034, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1657-4151","authenticated-orcid":false,"given":"Yining","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University First Hospital 100034, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"2021111620264440100_B1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","article-title":"Global, regional, and national burden of stroke, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Johnson","year":"2019","journal-title":"The Lancet Neurol."},{"key":"2021111620264440100_B2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jns.2011.10.029","article-title":"Stroke subtype classification: a comparative study of ASCO and modified TOAST","volume":"314","author":"Shang","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"2021111620264440100_B3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/CIRCRESAHA.116.308334","article-title":"Atherosclerosis: Successes, Surprises, and Future Challenges","volume":"118","author":"Libby","year":"2016","journal-title":"Circ. Res."},{"key":"2021111620264440100_B4","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.bbalip.2013.12.003","article-title":"The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration\u2014from cell and animal models to human disorders","volume":"1841","author":"Taniguchi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"2021111620264440100_B5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.plipres.2014.01.004","article-title":"Ceramide: a simple sphingolipid with unique biophysical properties","volume":"54","author":"Castro","year":"2014","journal-title":"Prog. Lipid Res."},{"key":"2021111620264440100_B6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/01.RES.86.2.198","article-title":"Rapid Activation of Neutral Sphingomyelinase by Hypoxia-Reoxygenation of Cardiac Myocytes","volume":"86","author":"Hernandez","year":"2000","journal-title":"Circ Res."},{"key":"2021111620264440100_B7","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/ATVBAHA.109.201681","article-title":"Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation","volume":"30","author":"Schwartz","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021111620264440100_B8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/00041433-199810000-00012","article-title":"The response-to-retention hypothesis of atherogenesis reinforced","volume":"9","author":"Williams","year":"1998","journal-title":"Curr. Opin. Lipidol."},{"key":"2021111620264440100_B9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1161\/CIRCRESAHA.109.194613","article-title":"Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice","volume":"105","author":"Liu","year":"2009","journal-title":"Circ. Res."},{"key":"2021111620264440100_B10","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1161\/hh0801.089604","article-title":"Ceramide Reduces Endothelium-Dependent Vasodilation by Increasing Superoxide Production in Small Bovine Coronary Arteries","volume":"88","author":"Zhang","year":"2001","journal-title":"Circ Res."},{"key":"2021111620264440100_B11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1159\/000051091","article-title":"Lactosylceramide Mediates Shear-Induced Endothelial Superoxide Production and Intercellular Adhesion Molecule-1 Expression","volume":"38","author":"Yeh","year":"2001","journal-title":"J. Vasc. Res."},{"key":"2021111620264440100_B12","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1161\/ATVBAHA.118.311199","article-title":"Plasma Ceramides-A Novel Predictor of Major Adverse Cardiovascular Events After Coronary Angiography","volume":"38","author":"Meeusen","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021111620264440100_B13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12574-017-0340-x","article-title":"Fabry disease","volume":"15","author":"Yuasa","year":"2017","journal-title":"J. Echocardiogr"},{"key":"2021111620264440100_B14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"key":"2021111620264440100_B15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/jmedgenet-2014-102872","article-title":"Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease","volume":"52","author":"Smid","year":"2015","journal-title":"J. Med. Genet."},{"key":"2021111620264440100_B16","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"The Lancet Neurol."},{"key":"2021111620264440100_B17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1474-4422(02)00190-4","article-title":"Subcortical ischaemic vascular dementia","volume":"1","author":"Rom\u00e1n","year":"2002","journal-title":"The Lancet Neurol."},{"key":"2021111620264440100_B18","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.2337\/db14-0559","article-title":"Perilipin 5 Regulates Islet Lipid Metabolism and Insulin Secretion in a cAMP-Dependent Manner: Implication of Its Role in the Postprandial Insulin Secretion","volume":"64","author":"Trevino","year":"2015","journal-title":"Diabetes"},{"key":"2021111620264440100_B19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/ijo.2017.63","article-title":"Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss","volume":"41","author":"Kayser","year":"2017","journal-title":"Int. J. Obes. (Lond)"},{"key":"2021111620264440100_B20","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/jn\/nxz048","article-title":"Identification of Plasma Lipid Metabolites Associated with Nut Consumption in US Men and Women","volume":"149","author":"Malik","year":"2019","journal-title":"J. Nutr."},{"key":"2021111620264440100_B21","doi-asserted-by":"publisher","first-page":"H605","DOI":"10.1152\/ajpheart.00697.2002","article-title":"Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries","volume":"284","author":"Zhang","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021111620264440100_B22","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1172\/JCI118934","article-title":"Rabbit Aorta and Human Atherosclerotic Lesions Hydrolyze the Sphingomyelin of Retained Low-density Lipoprotein","volume":"98","author":"Schissel","year":"1996","journal-title":"J. Clin. Invest."},{"key":"2021111620264440100_B23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1042\/CS20191028","article-title":"Myriocin and d-PDMP ameliorate atherosclerosis in ApoE-\/- mice via reducing lipid uptake and vascular inflammation","volume":"134","author":"Yu","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021111620264440100_B24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.plipres.2011.11.001","article-title":"Chain length-specific properties of ceramides","volume":"51","author":"Grosch","year":"2012","journal-title":"Prog. Lipid Res."},{"key":"2021111620264440100_B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2018.12.031","article-title":"CerS1-Derived C18:0 Ceramide in Skeletal Muscle Promotes Obesity-Induced Insulin Resistance","volume":"26","author":"Turpin-Nolan","year":"2019","journal-title":"Cell Rep."},{"key":"2021111620264440100_B26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","article-title":"CerS2 haploinsufficiency inhibits beta-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance","volume":"20","author":"Raichur","year":"2014","journal-title":"Cell Metab."},{"key":"2021111620264440100_B27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab."},{"key":"2021111620264440100_B28","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1038\/s41467-018-05613-7","article-title":"A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism","volume":"9","author":"Turner","year":"2018","journal-title":"Nat. Commun."},{"key":"2021111620264440100_B29","doi-asserted-by":"publisher","first-page":"H605","DOI":"10.1152\/ajpheart.00697.2002","article-title":"Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries","volume":"284","author":"Zhang","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021111620264440100_B30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/ijms20020411","article-title":"Ceramide and Regulation of Vascular Tone","volume":"20","author":"Cogolludo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"2021111620264440100_B31","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.2337\/db11-1399","article-title":"Ceramide Mediates Vascular Dysfunction in Diet-Induced Obesity by PP2A-Mediated Dephosphorylation of the eNOS-Akt Complex","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"key":"2021111620264440100_B32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol."},{"key":"2021111620264440100_B33","doi-asserted-by":"publisher","first-page":"170069","DOI":"10.1098\/rsob.170069","article-title":"Sphingolipids: membrane microdomains in brain development, function and neurological diseases","volume":"7","author":"Olsen","year":"2017","journal-title":"Open Biol."},{"key":"2021111620264440100_B34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/jnnp.2009.204685","article-title":"Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations","volume":"82","author":"Gouw","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2021111620264440100_B35","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3389\/fneur.2019.00950","article-title":"Plasma Lipid Profiling Identifies Biomarkers of Cerebral Microvascular Disease","volume":"10","author":"Azizkhanian","year":"2019","journal-title":"Front Neurol."},{"key":"2021111620264440100_B36","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1021\/acs.jproteome.9b00370","article-title":"Sphingolipidomics Investigation of the Temporal Dynamics after Ischemic Brain Injury","volume":"18","author":"Chao","year":"2019","journal-title":"J. Proteome Res."},{"key":"2021111620264440100_B37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.33594\/000000184","article-title":"The Acid Sphingomyelinase\/ Ceramide System as Target for Ischemic Stroke Therapies","volume":"27","author":"Mohamud Yusuf","year":"2019","journal-title":"Neurosignals"},{"key":"2021111620264440100_B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20160402","article-title":"Case study on the pathophysiology of Fabry disease: abnormalities of cellular membranes can be reversed by substrate reduction in vitro","volume":"37","author":"Brogden","year":"2017","journal-title":"Biosci. Rep."},{"key":"2021111620264440100_B39","doi-asserted-by":"publisher","first-page":"FSO147","DOI":"10.4155\/fsoa-2016-0027","article-title":"Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion","volume":"2","author":"Kamani","year":"2016","journal-title":"Future Sci. OA"},{"key":"2021111620264440100_B40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.gene.2013.11.073","article-title":"Reduced glucosylceramide in the mouse model of Fabry disease: correction by successful enzyme replacement therapy","volume":"536","author":"Quinta","year":"2014","journal-title":"Gene"},{"key":"2021111620264440100_B41","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.bbalip.2013.11.004","article-title":"Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses","volume":"1841","author":"Ferraz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"2021111620264440100_B42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","article-title":"Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells","volume":"95","author":"Shen","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"2021111620264440100_B43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1212\/01.wnl.0000338566.54190.8a","article-title":"Diagnostic utility of different MRI and MR angiography measures in Fabry disease","volume":"72","author":"Fellgiebel","year":"2009","journal-title":"Neurology"},{"key":"2021111620264440100_B44","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1161\/STROKEAHA.114.008548","article-title":"Brain magnetic resonance imaging findings fail to suspect Fabry disease in young patients with an acute cerebrovascular event","volume":"46","author":"Fazekas","year":"2015","journal-title":"Stroke"}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20201519\/893357\/bsr-2020-1519.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20201519\/893357\/bsr-2020-1519.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T20:55:13Z","timestamp":1637096113000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/40\/9\/BSR20201519\/226184\/Plasma-lipidomic-analysis-of-sphingolipids-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,30]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20201519","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,9]]},"article-number":"BSR20201519"}}